Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-13

Clinical Trial Update: Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nomogram-based versus standard allocation of acute normovolemic hemodilution during hepatic resection for liver cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Liver Cancer | Phase 3 | Status: COMPLETED